| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $0 | — |
| R&D Expense | $3.8M | +15.8% |
| SG&A Expense | $1.8M | +45.7% |
| Operating Income | -$5.7M | -25.9% |
| Pre-tax Income | -$5.5M | -10.5% |
| Net Income | -$5.5M | -10.5% |
| EPS (Basic) | -$1.13 | +1.7% |
| EPS (Diluted) | -$1.13 | +1.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Short-term Investments | $2.8M | +0.0% |
| Current Assets | $1.9M | -55.2% |
| Total Assets | $2.0M | -54.8% |
| Current Liabilities | $943K | +43.9% |
| Total Liabilities | $943K | +43.9% |
| Stockholders' Equity | $1.0M | -72.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$4.2M | -13.8% |
| Investing Cash Flow | $2.8M | -41.3% |
| Financing Cash Flow | $2.0M | — |